Universe Pharmaceuticals Growth Metrics (2021-2025) | UPC

Growth Metrics Sep2021 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Sep2025
Growth Ratios
Assets Growth (1y) 243,521,825.10%-15.12%-1.40%-29.92%-29.75%-99.84%101,986,624.93%
Assets Growth (3y) 11,214.74%-90.11%951.92%
Assets Growth (5y) 7,420.72%
Cash & Equivalents Growth (1y) -19.69%70,604.67%-9.00%-100.00%-59.20%92,537,514.74%535.58%
Cash & Equivalents Growth (3y) -91.72%768.14%80.51%
Cash & Equivalents Growth (5y) 406.69%
Enterprise Value Growth (1y) -116.77%-26,155.92%8.09%99.98%70.26%-485,280.05%-404.15%
Enterprise Value Growth (3y) 48.51%-573.58%-80.37%
Enterprise Value Growth (5y) -406.69%
Property, Plant & Equipment (Net) Growth (1y) -100.00%-9.20%-16.86%-12.96%-14.99%96,434,596.00%0.43%
Property, Plant & Equipment (Net) Growth (3y) -99.06%9,034.54%9,346.84%
Property, Plant & Equipment (Net) Growth (5y) -4.14%
Shareholder's Equity Growth (1y) 125.89%75,083.64%-22.94%-20.83%-43.25%162,583.92%23.35%
Shareholder's Equity Growth (3y) 1,003.72%9,793.22%1,066.85%
Shareholder's Equity Growth (5y) 1,832.92%
Total Debt Growth (1y) -100.00%17,033.62%74,528.34%62.24%39.50%164,854,246.30%-95.06%
Total Debt Growth (3y) -98.21%76,996.42%4,993.48%
Total Debt Growth (5y) -14.13%